학술논문
Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee
Document Type
Article
Author
Source
In Cytotherapy May 2024 26(5):413-417
Subject
Language
ISSN
1465-3249